Vincent P. Willard, Ph.D.
Affiliations: | 2011 | Rice University, Houston, TX |
Area:
Biomedical EngineeringGoogle:
"Vincent Willard"Parents
Sign in to add mentor| Kyriacos A. Athanasiou | grad student | 2011 | UC Davis (BME Tree) | |
| (Characterization of the Temporomandibular Joint Disc and Fibrocartilage Engineering using Human Embryonic Stem Cells.) | ||||
| Farshid Guilak | post-doc | Duke (Biomechanics Tree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Estes BT, Enomoto M, Moutos FT, et al. (2021) Biological resurfacing in a canine model of hip osteoarthritis. Science Advances. 7: eabi5918 |
| Willard VP, Leddy HA, Palmer D, et al. (2021) Transient receptor potential vanilloid 4 as a regulator of induced pluripotent stem cell chondrogenesis. Stem Cells (Dayton, Ohio) |
| Adkar SS, Wu CL, Willard VP, et al. (2018) Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing. Stem Cells (Dayton, Ohio) |
| Tang R, Jing L, Willard VP, et al. (2018) Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells. Stem Cell Research & Therapy. 9: 61 |
| Adkar SS, Brunger JM, Willard VP, et al. (2017) Genome Engineering for Personalized Arthritis Therapeutics. Trends in Molecular Medicine |
| Brunger JM, Zutshi A, Willard VP, et al. (2017) Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs. Stem Cell Reports |
| Brunger JM, Zutshi A, Willard VP, et al. (2016) CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues. Arthritis & Rheumatology (Hoboken, N.J.) |
| Adkar SS, Willard VP, Brunger JM, et al. (2016) 318. Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells Molecular Therapy. 24: S128 |
| Diekman BO, Thakore PI, O'Connor SK, et al. (2015) Knockdown of the cell cycle inhibitor p21 enhances cartilage formation by induced pluripotent stem cells. Tissue Engineering. Part A. 21: 1261-74 |
| Brunger JM, Zutshi A, Willard VP, et al. (2015) 504. Targeted Genome Engineering of Induced Pluripotent Stem Cells To Produce Auto-Regulated Inflammation Resistance for Musculoskeletal Regenerative Medicine Molecular Therapy. 23: S201-S202 |